Authors:
Strohal, R
Mosser, R
Kittler, H
Wolff, K
Jansen, B
Brna, C
Stingl, G
Pehamberger, H
Citation: R. Strohal et al., MART-1/Melan-A and tyrosinase transcripts in peripheral blood of melanoma patients: PCR analyses and follow-up testing in relation to clinical stage and disease progression, MELANOMA RE, 11(5), 2001, pp. 543-548
Authors:
Lucas, T
Pratscher, B
Krishnan, S
Fink, D
Gunsberg, P
Wolschek, M
Wacheck, V
Muster, T
Romirer, I
Wolff, K
Pehamberger, H
Eichler, HG
Rangnekar, VM
Jansen, B
Citation: T. Lucas et al., Differential expression levels of Par-4 in melanoma, MELANOMA RE, 11(4), 2001, pp. 379-383
Authors:
Guven, K
Kittler, H
Wolff, K
Pehamberger, H
Citation: K. Guven et al., Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients, MELANOMA RE, 11(4), 2001, pp. 411-415
Authors:
Kittler, H
Binder, M
Wolff, K
Pehamberger, H
Citation: H. Kittler et al., A ten-year analysis of demographic trends for cutaneous melanoma: Analysisof 2501 cases treated at the University Department of Dermatology in Vienna (1990-1999), WIEN KLIN W, 113(9), 2001, pp. 321-327
Authors:
Bergmann, M
Romirer, I
Sachet, M
Fleischhacker, R
Garcia-Sastre, A
Palese, P
Wolff, K
Pehamberger, H
Jakesz, R
Muster, T
Citation: M. Bergmann et al., A genetically engineered influenza A virus with ras-dependent oncolytic properties, CANCER RES, 61(22), 2001, pp. 8188-8193
Authors:
Joukhadar, C
Klein, N
Mader, RM
Schrolnberger, C
Rizovski, B
Heere-Ress, E
Pehamberger, H
Strauchmann, N
Jansen, B
Muller, M
Citation: C. Joukhadar et al., Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma, CANCER, 92(8), 2001, pp. 2190-2196
Authors:
Binder, M
Kittler, H
Dreiseitl, S
Ganster, H
Wolff, K
Pehamberger, H
Citation: M. Binder et al., Computer-aided epiluminescence microscopy of pigmented skin lesions: the value of clinical data for the classification process, MELANOMA RE, 10(6), 2000, pp. 556-561
Authors:
Kittler, H
Pehamberger, H
Wolff, K
Binder, M
Citation: H. Kittler et al., Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: Patterns of modifications observed in early melanoma, atypical nevi, and common nevi, J AM ACAD D, 43(3), 2000, pp. 467-476
Authors:
Selzer, E
Pimentel, E
Wacheck, W
Schlegel, W
Pehamberger, H
Jansen, B
Kodym, R
Citation: E. Selzer et al., Effects of betulinic acid alone and in combination with irradiation in human melanoma cells, J INVES DER, 114(5), 2000, pp. 935-940
Authors:
Schreiber, S
Kampgen, E
Wagner, E
Pirkhammer, D
Trcka, J
Korschan, H
Lindemann, A
Dorffner, R
Kittler, H
Kasteliz, F
Kupcu, Z
Sinski, A
Zatloukal, K
Buschle, M
Schmidt, W
Birnstiel, M
Kempe, RE
Voigt, T
Weber, HA
Pehamberger, H
Mertelsmann, R
Brocker, EB
Wolff, K
Stingl, G
Citation: S. Schreiber et al., Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2 transfected cancer cells: Outcome of a phase I study, HUM GENE TH, 10(6), 1999, pp. 983-993
Authors:
Jansen, B
Heere-Ress, E
Schlagbauer-Wadl, H
Halaschek-Wiener, J
Waltering, S
Moll, I
Pehamberger, H
Marciano, D
Kloog, Y
Wolff, K
Citation: B. Jansen et al., Farnesylthiosalicylic acid inhibits the growth of human Merkel cell carcinoma in SCID mice, J MOL MED-J, 77(11), 1999, pp. 792-797
Authors:
Kittler, H
Seltenheim, M
Dawid, M
Pehamberger, H
Wolff, K
Binder, M
Citation: H. Kittler et al., Morphologic changes of pigmented skin lesions: A useful extension of the ABCD rule for dermatoscopy, J AM ACAD D, 40(4), 1999, pp. 558-562
Authors:
Schlagbauer-Wadl, H
Griffioen, M
van Elsas, A
Schrier, PI
Pustelnik, T
Eichler, HG
Wolff, K
Pehamberger, H
Jansen, B
Citation: H. Schlagbauer-wadl et al., Influence of increased c-Myc expression on the growth characteristics of human melanoma, J INVES DER, 112(3), 1999, pp. 332-336
Authors:
Strohal, R
Brna, C
Mossbacher, U
Fischer, G
Pehamberger, H
Stingl, G
Citation: R. Strohal et al., First comparative delineation of the T cell receptor repertoire in primaryand multiple subsequent/coexisting metastatic melanoma sites (vol 111, pg 1085, 1998), J INVES DER, 112(2), 1999, pp. 256-256